Diagnosis and staging of fibrosis in patients with chronic hepatitis C: comparison and critical overview of current strategies

Leandro César Mendes, Raquel SB Stucchi, Aline G Vigani Department of Infectious Diseases, State University of Campinas, Campinas, SP, Brazil Abstract: In the past years, what has always been considered undisputed true in liver fibrosis staging has been challenged. Diagnostic performance...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mendes LC, Stucchi RSB, Vigani AG
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://doaj.org/article/8feab77c7a024ef18c1ee775ab706ce0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8feab77c7a024ef18c1ee775ab706ce0
record_format dspace
spelling oai:doaj.org-article:8feab77c7a024ef18c1ee775ab706ce02021-12-02T02:17:14ZDiagnosis and staging of fibrosis in patients with chronic hepatitis C: comparison and critical overview of current strategies1179-1535https://doaj.org/article/8feab77c7a024ef18c1ee775ab706ce02018-04-01T00:00:00Zhttps://www.dovepress.com/diagnosis-and-staging-of-fibrosis-in-patients-with-chronic-hepatitis-c-peer-reviewed-article-HMERhttps://doaj.org/toc/1179-1535Leandro César Mendes, Raquel SB Stucchi, Aline G Vigani Department of Infectious Diseases, State University of Campinas, Campinas, SP, Brazil Abstract: In the past years, what has always been considered undisputed true in liver fibrosis staging has been challenged. Diagnostic performance of histological evaluation has proven to be significantly influenced by sample- and observer-related variabilities. Differentiation between lower levels of fibrosis remains difficult for many, if not all, test modalities, including liver biopsy but, perhaps, such a distinction is not indispensable in light of current therapeutic approaches. Biomarkers and elastography offer, nonetheless, high predictive values for advanced fibrosis and cirrhosis and correlate well with liver-related outcomes. Necroinflammation, steatosis, and hemodynamic changes may significantly interfere with elastography-based techniques, and longitudinal follow-up strategies must be tailored in light of these findings. Knowledge of different test modalities and diagnostic performance indicators can allow for better clinical decision-making and resource allocation. Keywords: chronic hepatitis C, fibrosis, staging, elastography, biomarkersMendes LCStucchi RSBVigani AGDove Medical Pressarticlechronic hepatitis CfibrosisstagingelastographybiomarkersDiseases of the digestive system. GastroenterologyRC799-869ENHepatic Medicine: Evidence and Research, Vol Volume 10, Pp 13-22 (2018)
institution DOAJ
collection DOAJ
language EN
topic chronic hepatitis C
fibrosis
staging
elastography
biomarkers
Diseases of the digestive system. Gastroenterology
RC799-869
spellingShingle chronic hepatitis C
fibrosis
staging
elastography
biomarkers
Diseases of the digestive system. Gastroenterology
RC799-869
Mendes LC
Stucchi RSB
Vigani AG
Diagnosis and staging of fibrosis in patients with chronic hepatitis C: comparison and critical overview of current strategies
description Leandro César Mendes, Raquel SB Stucchi, Aline G Vigani Department of Infectious Diseases, State University of Campinas, Campinas, SP, Brazil Abstract: In the past years, what has always been considered undisputed true in liver fibrosis staging has been challenged. Diagnostic performance of histological evaluation has proven to be significantly influenced by sample- and observer-related variabilities. Differentiation between lower levels of fibrosis remains difficult for many, if not all, test modalities, including liver biopsy but, perhaps, such a distinction is not indispensable in light of current therapeutic approaches. Biomarkers and elastography offer, nonetheless, high predictive values for advanced fibrosis and cirrhosis and correlate well with liver-related outcomes. Necroinflammation, steatosis, and hemodynamic changes may significantly interfere with elastography-based techniques, and longitudinal follow-up strategies must be tailored in light of these findings. Knowledge of different test modalities and diagnostic performance indicators can allow for better clinical decision-making and resource allocation. Keywords: chronic hepatitis C, fibrosis, staging, elastography, biomarkers
format article
author Mendes LC
Stucchi RSB
Vigani AG
author_facet Mendes LC
Stucchi RSB
Vigani AG
author_sort Mendes LC
title Diagnosis and staging of fibrosis in patients with chronic hepatitis C: comparison and critical overview of current strategies
title_short Diagnosis and staging of fibrosis in patients with chronic hepatitis C: comparison and critical overview of current strategies
title_full Diagnosis and staging of fibrosis in patients with chronic hepatitis C: comparison and critical overview of current strategies
title_fullStr Diagnosis and staging of fibrosis in patients with chronic hepatitis C: comparison and critical overview of current strategies
title_full_unstemmed Diagnosis and staging of fibrosis in patients with chronic hepatitis C: comparison and critical overview of current strategies
title_sort diagnosis and staging of fibrosis in patients with chronic hepatitis c: comparison and critical overview of current strategies
publisher Dove Medical Press
publishDate 2018
url https://doaj.org/article/8feab77c7a024ef18c1ee775ab706ce0
work_keys_str_mv AT mendeslc diagnosisandstagingoffibrosisinpatientswithchronichepatitisccomparisonandcriticaloverviewofcurrentstrategies
AT stucchirsb diagnosisandstagingoffibrosisinpatientswithchronichepatitisccomparisonandcriticaloverviewofcurrentstrategies
AT viganiag diagnosisandstagingoffibrosisinpatientswithchronichepatitisccomparisonandcriticaloverviewofcurrentstrategies
_version_ 1718402609375608832